Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: Implementation of non-invasive fluorescence imaging

Molecular Imaging and Biology

Volumn 13, Issue 1, 2011, Pages 43-52

  Kamensek, Urska ^a   Sersa, Gregor ^a   Vidic, Suzana ^a   Tevz, Gregor ^a   Kranjc, Simona ^a   Cemazar, Maja ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Cisplatin; CMV promoter; Demethylation; Fibrosarcoma; Fluorescence imaging; In vivo; Irradiation; Mammary carcinoma; Mice

Indexed keywords

AZACITIDINE; CISPLATIN; GREEN FLUORESCENT PROTEIN; PROTEIN P21; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA METHYLATION; DRUG ACTIVITY; FEMALE; FIBROSARCOMA; FLUORESCENCE; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; LEG MUSCLE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; TUMOR CELL; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; AZACITIDINE; CELL LINE, TUMOR; CISPLATIN; CYTOMEGALOVIRUS; DNA METHYLATION; FEMALE; GENES, IMMEDIATE-EARLY; GENES, REPORTER; INFRARED RAYS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MUSCLES; PROMOTER REGIONS, GENETIC; UP-REGULATION;

CYTOMEGALOVIRUS; MAMMALIA; MURINAE; MUS;

EID: 79551594992     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0300-6     Document Type: Article

References (39)

1. AR Brooks RN Harkins PY Wang, et al. 2004 Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle J Gene Med 6 395 404 1:CAS:528:DC%2BD2cXksVSnt70%3D 10.1002/jgm.516 15079814
2. G Escher A Hoang S Georges, et al. 2005 Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages J Lipid Res 46 356 365 1:CAS:528: DC%2BD2MXhvFGku70%3D 10.1194/jlr.D400014-JLR200 15520456
3. G Grassi P Maccaroni H Kaiser, et al. 2003 Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87 Carcinogenesis 24 1625 1635 1:CAS:528:DC%2BD3sXotVCls7Y%3D 10.1093/carcin/bgg118 12869421
4. K Hong J Sherley DA Lauffenburger 2001 Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector Biomol Eng 18 185 192 1:CAS:528:DC%2BD3MXotl2gsbw%3D 10.1016/S1389-0344(01)00100-9 11576873
5. S Prosch J Stein K Staak, et al. 1996 Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro Biol Chem 377 195 201 1:STN:280:DyaK283ptVOjsg%3D%3D
6. IA Pringle S Raman WW Sharp, et al. 2005 Detection of plasmid DNA vectors following gene transfer to the murine airways Gene Ther 12 1206 1214 1:CAS:528:DC%2BD2MXmtlCrs7w%3D 10.1038/sj.gt.3302518 15800657
7. P Loser GS Jennings M Strauss V Sandig 1998 Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NF kappa B J Virol 72 180 190 1:CAS:528: DyaK1cXhvVCguw%3D%3D 9420214
8. Y Lee WJ Sohn DS Kim HJ Kwon 2004 NF-kappa B- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7 Eur J Biochem 271 1094 1105 1:CAS:528: DC%2BD2cXislSmsrk%3D 10.1111/j.1432-1033.2004.04011.x 15009188
9. M Ramanathan G Hasko SJ Leibovich 2005 Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale Inflammation 29 94 102 1:CAS:528:DC%2BD28XpvFamtbk%3D 10.1007/s10753-006-9005-z 16865543
10. AJ Simpson GA Cunningham DJ Porteous C Haslett JM Sallenave 2001 Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide Hum Gene Ther 12 1395 1406 1:CAS:528:DC%2BD3MXls1WgsLc%3D 10.1089/104303401750298553 11485631
11. T Stamminger H Fickenscher B Fleckenstein 1990 Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic-amp J Gen Virol 71 105 113 1:CAS:528:DyaK3cXhtFeit7Y%3D 10.1099/0022-1317-71-1-105 2154528
12. W Bruening B Giasson W Mushynski HD Durham 1998 Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter Nucleic Acids Res 26 486 489 1:CAS:528:DyaK1cXnvVSqsA%3D%3D 10.1093/nar/26.2.486 9421504
13. T Egami K Huchida K Mizumoto, et al. 2008 Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake Clin Cancer Res 14 1859 1867 1:CAS:528: DC%2BD1cXjtleisrY%3D 10.1158/1078-0432.CCR-07-0933 18347189
14. RU Svensson JM Barnes OW Rokhlin NB Cohen MD Henry 2007 Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy Cance Res 67 10445 10454 1:CAS:528:DC%2BD2sXht1erurrM 10.1158/0008-5472.CAN-07-1955
15. JK Raty T Liimatainen MU Kaikkonen, et al. 2007 Non-invasive imaging in gene therapy Mol Ther 15 2052 10.1038/sj.mt.6300272
16. JH Kang JK Chung 2008 Molecular-genetic imaging based on reporter gene expression J Nuc Med 49 164S 179S 1:CAS:528:DC%2BD1cXotFahu70%3D 10.2967/jnumed.107.045955
17. SJ Kim TK Varghese Z Zhang, et al. 2005 Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoter Am J Transplant 5 1606 1613 1:CAS:528:DC%2BD2MXmsV2lt70%3D 10.1111/j.1600-6143.2005.00912.x 15943618
18. WS Eldeiry T Tokino VE Velculescu, et al. 1993 Waf1, a potential mediator of P53 tumor suppression Cell 75 817 825 1:CAS:528:DyaK2cXpslGguw%3D%3D 10.1016/0092-8674(93)90500-P
19. K Harada GR Ogden 2000 An overview of the cell cycle arrest protein, p21(WAF1) Oral Oncol 36 3 7 1:CAS:528:DyaK1MXotVOhsbg%3D 10.1016/S1368-8375(99) 00049-4 10928815
20. P Nanni C Degiovanni PL Lollini G Nicoletti G Prodi 1983 Ts/A - a new metastasizing cell-line from A Balb/C spontaneous mammary adenocarcinoma Clin Exp Metas 1 373 380 1:STN:280:DyaL283nt1ymtQ%3D%3D 10.1007/BF00121199
21. J Belehradek G Barski M Thonier 1972 Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated cells Int J Cancer 9 461 469 10.1002/ijc.2910090302 4660932
22. J Teissie JM Escoffre MP Rols M Golzio 2008 Time dependence of electric field effects on cell membranes A review for a critical selection of pulse duration for therapeutical applications. Radiol Oncol 42 196 206
23. G Tevz D Pavlin U Kamensek, et al. 2008 Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression Technol Cancer Res T 7 91 101 1:CAS:528:DC%2BD1cXlslagsrY%3D
24. BW O'Malley DQ Li SJ McQuone R Ralston 2005 Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside Laryngoscope 115 391 404 10.1097/00005537-200503000-00002 15744147
25. PA Furth L Hennighausen C Baker B Beatty R Woychick 1991 The variability in activity of the universally expressed human cytomegalovirus immediate early gene-1 enhancer promoter in transgenic mice Nucleic Acids Res 19 6205 6208 1:CAS:528:DyaK38XjsFarug%3D%3D 10.1093/nar/19.22.6205 1956779
26. JF Baskar PP Smith G Nilaver, et al. 1996 The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice J Virol 70 3207 3214 1:CAS:528:DyaK28Xit1Ogsrs%3D 8627801
27. NS Yew M Przybylska RJ Ziegler DP Liu SH Cheng 2001 High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter Mol Ther 4 75 82 1:CAS:528:DC%2BD38XhvFKiu7c%3D 10.1006/mthe.2001.0415 11472109
28. T Ritter C Brandt S Prosch, et al. 2000 Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells Cytokine 12 1163 1170 1:CAS:528:DC%2BD3cXltlOqsLc%3D 10.1006/cyto.2000.0689 10930292
29. T Vaissiere C Sawan Z Herceg 2008 Epigenetic interplay between histone modifications and DNA methylation in gene silencing Mutat Res-Rev Mutat 659 40 48 1:CAS:528:DC%2BD1cXpsVams7o%3D
30. R Jaenisch A Schnieke K Harbers 1985 Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues P Natl Acad Sci USA 82 1451 1455 1:CAS:528:DyaL2MXhvVSjtLc%3D 10.1073/pnas.82.5.1451
31. M Krishnan JM Park F Cao, et al. 2005 Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging Faseb J 19 106
32. M Di Ianni A Terenzi K Perruccio, et al. 1999 5-Azacytidine prevents transgene methylation in vivo Gene Ther 6 703 707 10.1038/sj.gt.3300848 10476232
33. RL Momparler 2005 Epigenetic therapy of cancer with 5-aza-2 '-deoxycytidine (decitabine) Sem Oncol 32 443 451 1:CAS:528:DC%2BD2MXhtFyhtbnE 10.1053/j.seminoncol.2005.07.008
34. T Deng Y Zhang 2009 Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine Life Sci 84 311 320 1:CAS:528:DC%2BD1MXitVCqsbs%3D 10.1016/j.lfs.2008.12.015 19159630
35. AR Karpf BE Moore TO Ririe DA Jones 2001 Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine Mol Pharmacol 59 751 757 1:CAS:528:DC%2BD3MXisVSqsro%3D 11259619
36. SMK Pulukuri JS Rao 2005 Activation of p53/p21(Waf1/Cip1) pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells Int J Oncol 26 863 871 1:CAS:528:DC%2BD2MXjtFels7Y%3D 15753979
37. WG Zhu T Hileman Y Ke, et al. 2004 5-Aza-2'-deoxycytidine activates the p53/p21(Waf1/Cip1) pathway to inhibit cell proliferation J Biol Chem 279 15161 15166 1:CAS:528:DC%2BD2cXivVKgs7w%3D 10.1074/jbc.M311703200 14722112
38. R Schneider-Stock M ab-Assef A Rohrbeck, et al. 2005 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45-and p53-dependent mechanisms J Pharmacol Exp Ther 312 525 536 1:CAS:528:DC%2BD2MXhsVCnsLk%3D 10.1124/jpet.104.074195 15547111
39. KI Kim JH Kang JK Chung, et al. 2007 Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells J Nucl Med 48 1553 1561 1:CAS:528:DC%2BD2sXhtFGgsLnE 10.2967/jnumed.106. 038612 17704247